The effect of reiki on pain in women undergoing non-emergency caesarean sections
ISRCTN | ISRCTN79265996 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN79265996 |
Secondary identifying numbers | REB#-08-030 |
- Submission date
- 14/04/2009
- Registration date
- 27/05/2009
- Last edited
- 30/12/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
The Hospital for Sick Children
Division of Clinical Pharmacology, Rm 8232
555 University Ave
Toronto
M5G 1X8
Canada
Phone | +1 416 813 1500 ext. 5781 |
---|---|
gkoren@sickkids.ca |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | The effect of reiki on pain in women who will undergo non-emergency caesarean sections and the effect of genetic variation on the use of codeine: a randomised controlled trial |
Study acronym | REPA |
Study objectives | Can reiki reduce pain after caesarean section by more than 25%? |
Ethics approval(s) | St. Michael's Hospital Ethics Review Board approved on the 12th May 2008 (ref: 08-030) |
Health condition(s) or problem(s) studied | Pain levels after caesarean section |
Intervention | 1. Control group: usual care 2. Reiki Group: usual care plus 20 minutes of Remote Reiki Duration: three days while in the hospital. |
Intervention type | Other |
Primary outcome measure | Visual Analogue Scale for pain in movement, at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital'). |
Secondary outcome measures | 1. Visual Analogue Scale for pain (in rest) 2. Pain medication (codeine consumption/kg) 3. Return time to normal activities All measured at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital'). |
Overall study start date | 30/06/2008 |
Completion date | 30/04/2009 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Female |
Target number of participants | 80 |
Total final enrolment | 80 |
Key inclusion criteria | 1. Informed consent 2. Planned caesarean section 3. Pregnant women aged 18 - 48 years |
Key exclusion criteria | Does not meet with inclusion criteria |
Date of first enrolment | 30/06/2008 |
Date of final enrolment | 30/04/2009 |
Locations
Countries of recruitment
- Canada
Study participating centre
M5G 1X8
Canada
Sponsor information
Hospital/treatment centre
c/o Gideon Koren
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
Division of Clinical Pharmacology, Rm 8232
555 University Ave
Toronto
M5G 1X8
Canada
Website | http://www.sickkids.ca/ |
---|---|
https://ror.org/057q4rt57 |
Funders
Funder type
Other
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 26/02/2011 | 30/12/2020 | Yes | No |
Editorial Notes
30/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.